2024 annual financial data
MaxCyte 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -71.48%.
Operating income was -51,197,000 USD and net income was -41,055,000 USD.
Operating cash flow was -27,610,000 USD.
Get free MaxCyte email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 38,627,000 USD
- Operating income
- -51,197,000 USD
- Net income
- -41,055,000 USD
- Operating cash flow
- -27,610,000 USD